Neuroendocrine responses to laboratory panic: Cognitive intervention in the doxapram model

Psychoneuroendocrinology

Volumn 21, Issue 4, 1996, Pages 375-390

  Abelson, James L ^a   Weg, John G ^b   Nesse, Randolph M ^a   Curtis, George C ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Catecholamines; Cognition; Cortisol; Doxapram; Growth hormone; Panic disorder

Indexed keywords

ADRENALIN; CORTICOTROPIN; DOXAPRAM; GROWTH HORMONE; HYDROCORTISONE; NORADRENALIN; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; PANIC; PRIORITY JOURNAL;

EID: 0030152074     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4530(96)00005-4     Document Type: Article

References (40)

1. Abelson JL, Curtis GC (1986) Hypothalamic-pituitary-adrenal axis activity in panic disorder: 24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry 53:323-331.
2. Abelson JL, Nesse RM, Vinik AI (1994) Pentagastrin infusions in patients with panic disorder I.I. Neuroendocrinology. Biol Psychiatry 36:84-96.
3. Abelson JL, Nesse RM, Weg JG, Curtis GC (in press) Respiratory psychophysiology and anxiety: Cognitive intervention in the doxapram model of panic. Psychosom Med.
4. Albus M, Zahn TP, Breier A (1992) Anxiogenic properties of yohimbine: I. Behavioral, physiological and biochemical measures. Eur Arch Psychiatry Clin Neurosci 241:337-344.
5. Aronson TA, Carasiti I, McBane D, Whitaker-Azmitia P (1989) Biological correlates of lactate sensitivity in panic disorder. Biol Psychiatry 26:463-477.
6. Breier A, Albus M, Pickar D, Zahn TP, Wolkowitz OM, Paul SM (1987) Controllable and uncontrollable stress in humans: alterations in mood and neuroendocrine and psychophysiological function. Am J Psychiatry 144:1419-1425.
7. Burki NK (1984) Ventilatory effects of doxapram in conscious human subjects. Chest 85:600-604.
8. Calverley PMA, Robson RH, Wraith PK, Prescott LF, Flenley DC (1983) The ventilatory effects of doxapram in normal man. Clin Sci 65:65-69.
9. Cameron OG, Lee MA, Curtis GC, McCann DS (1987) Endocrine and physiological changes during 'spontaneous' panic attacks. Psychoneuroendocrinology 12:321-331.
10. Carr DB, Sheehan DV, Surman OS, Coleman JH, Greenblatt DJ, Heninger GR, Jones KJ, Levine PH, Watkins WD (1986) Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. Am J Psychiatry 143:483-494.
11. Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:751-763.
12. Clark DM (1993) Cognitive mediation of panic attacks induced by biological challenge tests. Adv Behav Res Ther 15:75-84.
13. Croes S, Merz P, Netter P (1993) Cortisol reaction in success and failure condition in endogenous depressed patients and controls. Psychoneuroendocrinology 18:23-35.
14. Curtis GC, Nesse R, Buxton MDL (1978) Anxiety and plasma cortisol at the crest of the circadian cycle: reappraisal of a classical hypothesis. Psychosom Med 40:368-378.
15. Dimsdale JE, Moss J (1980) Short-term catecholamine response to psychological stress. Psychosom Med 42:493-497.
16. Folgering H, Vis A, Ponte J (1981) Ventilatory and circulatory effects of doxapram, mediated by carotid body chemoreceptors. Bull Eur Physiopathol Resp 17:237-241.
17. German JM, Fyer MR, Goetz R, Ashkanazi J, Liebowitz M, Fyer AJ, Kinney J, Klein DF (1988) Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 45:31-39.
18. Gurguis GNM, Mefford IN, Uhde TW (1991) Hypothalamic-pituitary-adrenocortical activity in panic disorder: relationship to plasma catecholamine metabolites. Biol Psychiatry 30:502-506.
19. Holsboer F, Bardeleben U von, Buller R, Heuser I, Steiger A (1987) Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Horm Metab Res 16(suppl.):80-88.
20. Insel TR, Ninan PT, Aloi J, Jimerson DC, Skolnick P, Paul SM (1984) A benzodiazepine receptor-mediated model of anxiety. Arch Gen Psychiatry 41:741-750.
21. Kellner M, Herzog L, Yassouridis A, Holsboer F, Wiedemann K (1995) Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic. Am J Psychiatry 152:1365-1367.
22. Kellner M, Wiedemann K, Holsboer F (1992) Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci 50:1835-1842.
23. Kirschbaum C, Wüst S, Hellhammer D (1992) Consistent sex differences in cortisol response to psychological stress. Psychosom Med 54:648-657.
24. Klein DF (1993) False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Arch Gen Psychiatry 50:306-317.
25. Klein DF (1994) Testing the suffocation false alarm theory of panic disorder. Anxiety 1:1-7.
26. Lee YJ, Curtis GC, Weg JG, Abelson JL, Modell JG, Campbell K (1993) Panic attacks induced by doxapram. Biol Psychiatry 33:295-297.
27. Levin AP, Doran AR, Liebowitz MR, Fyer AJ, Gorman JM, Klein DF, Paul SM (1987) Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatr Res 21:23-32.
28. Levine S (1992) The Psychoneuroendocrinology of stress. Ann NY Acad Sci 697:61-69.
29. Papp LA, Klein DF, Gorman JM (1993) Carbon dioxide hypersensitivity, hyperventilation, and panic disorder. Am J Psychiatry 150:1149-1157.
30. Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW (1986) The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 143:896-899.
31. Sanderson WC, Rapee RM, Barlow DH (1989) The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide enriched air. Arch Gen Psychiatry 46:157-162.
32. Spitzer RL, Williams JBW (1986) Structured Clinical Interview for DSM-III-R-Upjohn Version-Revised. Biometrics Research Department, New York State Psychiatric Institute.
33. Targum SD (1992) Cortisol response during different anxiogenic challenges in panic disorder patients. Psychoneuroendocrinology 17:453-458.
34. Uhde TW (1987) Noradrenergic studies in anxiety. In: Sen AK, Lee T (Eds) Receptors and Ligands in Psychiatry and Neurology. Cambridge University Press, London, pp 375-387.
35. Uhde TW, Boulenger JP, Jimerson DC, Post RM (1984) Caffeine: relationship to human anxiety, plasma MHPG and cortisol. Psychopharmacol Bull 20:426-430.
36. Uhde TW, Tancer ME, Rubinow DR, Roscow DB, Boulenger JP, Vittone B, Gurguis G, Geraci M, Black B, Post RM (1992) Evidence for hypothalamic-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. Neuropsychopharmacology 6:101-118.
37. Veith RC (1991) Sympathetic nervous system function in depression and panic disorder. In: Brown MR, Koob GF, Rivier C (Eds) Stress: Neurobiology and Neuroendocrinology. Marcel Dekker, New York, pp 395-435.
38. Weinberg J, Levine S (1980) Psychobiology of coping in animals: the effects of predictability. In: Levine S, Ursin H (Eds) Coping and Health. Plenum Press, New York, pp 39-59.
39. Winnie AP (1973) Chemical respirogenesis: a comparative study. Acta Anaesthesiol Scand 51 (Suppl.):1-32.
40. Woods SW, Charney DS, McPherson CA, Gradman AH, Heninger GR (1987) Situational panic attacks: behavioral, physiologic, and biochemical characterization. Arch Gen Psychiatry 44:365-375.